L-5-hydroxytryptophan in the prophylaxis of chronic tension-type headache: A double-blind, randomized, placebo-controlled study

Headache

Volumn 40, Issue 6, 2000, Pages 451-456

  Fontes Ribeiro, Carlos A ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Biomed Inst Res Light and Image   (Portugal)

Author keywords

5 HT; Chronic tension type headache; Controlled trial; L 5 hydroxytryptophan; Preventive treatment

Indexed keywords

5 HYDROXYTRYPTOPHAN;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; EPIGASTRIC PAIN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TENSION HEADACHE; URTICARIA;

5-HYDROXYTRYPTOPHAN; ADOLESCENT; ADULT; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLACEBOS; TENSION-TYPE HEADACHE;

EID: 0033932860     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2000.00067.x     Document Type: Article

References (22)

1. Diener HC, Edmeads J. General approach to treatment. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York, NY: Raven Press; 1993:513-514.
2. Holroyd KA. Psychological and behavioral techniques. In: Olesen J, Tfelt-Hansen P. Welch KMA, eds. The Headaches. New York, NY: Raven Press; 1993:515-520.
3. Carlsson J, Aisen M. Physiotherapy. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York, NY: Raven Press; 1993:521-525.
4. Couch JR, Micieli G. Prophylactic pharmacotherapy. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York, NY: Raven Press; 1993: 537-542.
5. Foster CA, Bafaloukos J. Paroxetine in the treatment of chronic daily headache. Headache. 1994;34: 587-589.
6. Langemark M, Olesen J. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache. 1994;34: 20-24.
7. Anthony M. Lance JW. Headache. In: Eadie MJ, ed. Drug Therapy in Neurology. New York, NY: Churchill Livingstone; 1992:335-374.
8. Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache. 1991;31:71-74.
9. Vijayan N, Spillane T. Valproic acid treatment of chronic daily headache. Headache. 1995;35:540-543.
10. Anthony M, Lance JW. Platelet scrotonin in patients with chronic tension headaches. J Neurol Neurosurg Psychiatry. 1989;52:182-184.
11. Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R, ed. Textbook of Pain. Edinburgh: Churchill Livingstone; 1994:243-257.
12. Chung KK, Martinez M, Herbert J. Central serotonin depletion modulates the behavioural, endocrine and physiological responses to repeated social stress and subsequent c-fos expression in the brains of male rats. Neuroscience. 1999;92:613-625.
13. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev. 1993;45:309-379.
14. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
15. International Headache Society Committee on Clinical Trials. Guidelines for trials of drug treatments in tension-type headache. Cephalalgia. 1995;15:165-179.
16. Meltzer HY, Arora RC. Platelet serotonin studies in affective disorders: evidence for a serotonergic abnormality? In: Sandler M, Coppen A, Harnett S, eds. 5-Hydroxytryptamine in Psychiatry. Oxford, England: Oxford Medical Publications; 1991:50-87.
17. Genazzani AR, Sandrini G, Facchinetti F, et al. Effects of L-5HTP with and without carbidopa on plasma beta-endorphin and pain perception. Possible implications in migraine prophylaxis. Cephalalgia. 1986;6:241-245.
18. De Benedittis G, Di Giulio AM, Massei R, Villani R, Panerai AE. Effects of 5-hydroxytryptophan on central and deafferentation chronic pain: a preliminary clinical trial. In: Bonica JJ, Lindblom U, Iggo A, eds. Advances in Pain Research and Therapy. V. Proceedings of the Third World Congress on Pain. New York, NY: Raven Press; 1983:295-304.
19. Boiardi A. Picotti GB, Di Giulio AM, et al. Platelet met-enkephalin immunoreactivity and 5-hydroxytryptamine concentrations in migraine patients: effects of 5-hydroxytryptophan, amitriptyline and chlorimipramine treatment. Cephalalgia. 1984;4:81-84.
20. Langemark M, Olesen J. Effervescent ASA versus solid ASA in the treatment of tension headache. A double-blind, placebo controlled study. Headache. 1987;27:90-95.
21. Pfaffenrath V, Diener HC, Isler H, et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia. 1994;14:149-155.
22. De Benedittis G, Massei R. Serotonin precursors in chronic primary headache. A double-blind cross-over study with L-5-hydroxytryptophan vs. placebo. J Neurosurg Sci. 1985;29:239-248.